Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ain HoldingsAINPF 93 5-Year Yield-on-Cost % is 2.15 as of Jul. 17, 2026, which is 57% above its 10-year median of 1.37. GuruFocus rates AINPF with a GF Score™ of 93/100 and a GF Value™ of $47.66 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 280 Healthcare Providers & Services companies, Ain Holdings ranks worse than 58.21% on this metric.
Ain Holdings's yield on cost for the quarter that ended in Jan. 2026 was 2.15.
The historical rank and industry rank for Ain Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
AINPF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.73 Med: 1.37 Max: 2.98
Current: 2.15
During the past 13 years, Ain Holdings's highest Yield on Cost was 2.98. The lowest was 0.73. And the median was 1.37.
AINPF's 5-Year Yield-on-Cost % is ranked worse than 58.21% of 280
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs AINPF: 2.15
Ain Holdings (OTCPK:AINPF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Ain Holdings 5-Year Yield-on-Cost % Related Terms
Ain Holdings 5-Year Yield-on-Cost % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Ain Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ain Holdings 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ain Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Ain Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Ain Holdings is calculated as
Ain Holdings (AINPF) has a 5-Year Yield-on-Cost % of 2.15 as of Jul. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ain Holdings and its competitors. This is 57% above median its historical median of 1.37. Over the past decade, Ain Holdings' 5-Year Yield-on-Cost % has ranged from 0.73 to 2.98. According to the industry distribution chart, Ain Holdings ranks #163 out of 280 companies in the Healthcare Providers & Services industry, placing it in the top 58.2%.
Is Ain Holdings' 5-Year Yield-on-Cost % too high?
Ain Holdings' current 5-Year Yield-on-Cost % of 2.15 is 57% above median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 2.98. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Ain Holdings' value of 2.15 is 26.6% below this industry median. Based on the distribution chart, Ain Holdings ranks #163 out of 280 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ain Holdings has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ain Holdings' 5-Year Yield-on-Cost % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Ain Holdings ranks #163 out of 280 companies for 5-Year Yield-on-Cost %. This places Ain Holdings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Ain Holdings' value of 2.15 is 26.6% below this benchmark. Historically, Ain Holdings' own 5-Year Yield-on-Cost % has ranged from 0.73 to 2.98 over the past decade. While the company's 10-year median is 1.37 vs. the industry median of 2.93, Ain Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ain Holdings's current 5-Year Yield-on-Cost % of 2.15 is 26.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ain Holdings and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ain Holdings's current 5-Year Yield-on-Cost % is 2.15, which is 57% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ain Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ain Holdings (AINPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $47.66, compared to a current price of $36.86 — trading 22.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.15, which is 57% above median its 10-year median of 1.37 and 26.6% below the Healthcare Providers & Services industry median of 2.93. Ain Holdings' overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Ain Holdings (AINPF), the current 5-Year Yield-on-Cost % is 2.15 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ain Holdings (AINPF) Overvalued in 2026?
Based on GuruFocus' analysis, Ain Holdings stock appears to be undervalued.
The current stock price of $36.86 is trading 22.7% below its estimated GF Value™ of $47.66.
GuruFocus considers Ain Holdings to be Modestly Undervalued.
Key valuation signals for AINPF:
5-Year Yield-on-Cost %: 2.15 (57% above median its 10-year median of 1.37)
GF Value™: $47.66 vs. price of $36.86 (22.7% below fair value)
Industry Position: 26.6% below the Healthcare Providers & Services median (#163 of 280)
No single metric tells the full story. See the AINPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ain Holdings Inc's core business is the dispensing pharmacy business that includes preparing and dispensing drugs based on prescriptions. The company also generates revenue by selling generic drugs wholesale, pharmacy staffing services, and pharmacy consulting services. The company's additional business activity includes both urban and suburban drug and cosmetic stores. Ain operates the ainz & tuple brand that specifically targets female consumers in urban areas. The company also executes small real estate rental strategies.
93GF Score
Get the complete analysis for AINPF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINPF has been successfully added to your 
